These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 5594897)

  • 1. [Essential hypertonia and its management].
    Achenbach-Maas
    Med Monatsschr; 1967 Mar; 21(3):126-9. PubMed ID: 5594897
    [No Abstract]   [Full Text] [Related]  

  • 2. A comparative study of metoprolol and methyldopa in the treatment of hypertension.
    Karachalios GN
    Int J Clin Pharmacol Ther Toxicol; 1983 Sep; 21(9):476-8. PubMed ID: 6629553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ethacrynic acid alone and in combination with methyldopa in the management of mild hypertension. A report of 23 patients.
    Gifford RW
    Int Z Klin Pharmakol Ther Toxikol; 1970 Jul; 3(3):255-60. PubMed ID: 4917428
    [No Abstract]   [Full Text] [Related]  

  • 4. Cardiovascular response to isometric stress (handgrip) in patients with essential hypertension before and after antihypertensive therapy with propranolol or alpha methyldopa.
    Baldwa VS; Gupta BS; Chittora MD
    Indian Heart J; 1983; 35(6):333-6. PubMed ID: 6667950
    [No Abstract]   [Full Text] [Related]  

  • 5. Study of phonocardiographic and apex cardiographic abnormalities in hypertensive disease and their responsiveness to alpha-methyldopa.
    Strausz I; Kékes E; Horányi P; Barcsák J
    Ther Hung; 1973; 21(3-4):97-100. PubMed ID: 4806428
    [No Abstract]   [Full Text] [Related]  

  • 6. [A combination of methyldopa, hydrochlorothiazide and amiloride in the treatment of essential hypertension].
    Bolzano K; Krempler F; Sandhofer F
    Acta Med Austriaca; 1984; 11(2):49-53. PubMed ID: 6377793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Methyldopa: study of the antihypertensive and renin-reducing effects at rest and after exercise].
    Sbissa AS; Sbissa LA; Thiesen AL; Zunino JN
    Arq Bras Cardiol; 1981 Sep; 37(3):213-7. PubMed ID: 7052027
    [No Abstract]   [Full Text] [Related]  

  • 8. [Changes in renal function and electrolyte transport after acute decrease of blood pressure induced by a decarboxylase inhibitor (alpha-methyldopa)].
    Koçak N; Kalkay N; Ozdoğan E
    Turk Tip Cemiy Mecm; 1967; 33(11):671-80. PubMed ID: 5598385
    [No Abstract]   [Full Text] [Related]  

  • 9. Long-term treatment of Hypertension with methyldopa. II. Therapeutic efficacy.
    Fitz AE; Saunders E
    J Cardiovasc Pharmacol; 1981; 3 Suppl 2():S85-91. PubMed ID: 6172671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of antihypertensive activity and tolerability of guanfacine and methyldopa.
    Malini PL; Strocchi E; Ambrosioni E; Magnani B
    Int J Clin Pharmacol Res; 1983; 3(1):35-9. PubMed ID: 6384071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparison between timolol maleate and alphamethyldopa in longterm treatment of essential hypertension (author's transl)].
    G Ital Cardiol; 1981; 11(12):2110-6. PubMed ID: 7346307
    [No Abstract]   [Full Text] [Related]  

  • 12. [Behavior of the blood pressure curve during the ergometric stress test, in treated and non-treated hypertensive patients].
    Carrasco RM; da Rocha MM; Luna RL
    Arq Bras Cardiol; 1981 Mar; 36 Suppl 1():24-32. PubMed ID: 7325860
    [No Abstract]   [Full Text] [Related]  

  • 13. [Therapeutic trials with the new antihypertensive agent Tadip].
    Stein G
    Med Klin; 1968 Sep; 63(37):1466-8. PubMed ID: 5730203
    [No Abstract]   [Full Text] [Related]  

  • 14. Methyldopa: an agent for the treatment of older patients with isolated systolic hypertension.
    Vaicaitis JS
    Clin Ther; 1984; 6(4):451-6. PubMed ID: 6467278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Alprenolol and alphamethyl-dopa in untreated cases of essential hypertension--a comparison].
    Bergstrand RH; Vedin JA; Wilhelmsson CE
    Lakartidningen; 1973 Aug; 70(33):2817-20. PubMed ID: 4597664
    [No Abstract]   [Full Text] [Related]  

  • 16. A comparative evaluation of aldactide and methyldopa in the management of benign essential hypertension.
    Nair KG; Jairam HN; Lal HM; Phaterpekar SJ
    J Assoc Physicians India; 1980; 28(1-2):7-13. PubMed ID: 7216969
    [No Abstract]   [Full Text] [Related]  

  • 17. Multiclinic evaluation of the antihypertensive effect of a methyldopa, hydrochlorothiazine, and amiloride combination.
    Moncloa F; Hwang IK; Muccilli AC
    Clin Ther; 1980; 3(3):168-75. PubMed ID: 7006811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evaluation by practicing physicians of the antihypertensive efficacy of debrisoquin, methyldopa and propranolol].
    Avigdor L; Waeber B; Brunner HR
    Schweiz Med Wochenschr; 1983 Mar; 113(9):331-8. PubMed ID: 6342133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term treatment of hypertension with methyldopa. VIII. Overview.
    Itskovitz HD
    J Cardiovasc Pharmacol; 1981; 3 Suppl 2():S120-7. PubMed ID: 6172668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Simplified treatment of hypertension using Tadip].
    Kumpmann U
    Med Welt; 1968 Nov; 46():2553-6. PubMed ID: 5731380
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.